TAT-CIRP is a a small peptide, refers to Trans-trans-activating (Tat)-cold-inducible RNA binding protein. TAT-CIRP is an inhibitor of myeloid differentiation protein 2 (MD2). TAT-CIRP exhibits robust neuroprotection against ischemic and hemorrhagic stroke in mice.
体外研究
TAT-CIRP (5 μM) alleviates NMDA-induced apoptosis and necrosis in neuronal cells (50 μM; 1 hour) via a TLR4-independent pathway.
体内研究
TAT-CIRP (5-20mg/kg) alleviates brain damage after ischemic stroke in mice with middle cerebral artery (MCAO) occlusion. As for Tat, the cell membrane transduction domain of human immunodeficiency virus type 1 can be used as a control peptide .
TAT-CIRP (20 mg/kg; intravenous injection; Single dose) can pass through the blood-brain barrier in mice, with a Cmax value of 4762.6 μ g/L and a half-life of approximately 90 minutes.
TAT-CIRP (20 mg/kg, 100 mg/kg; intravenous injection; Once a day for 7 days) has almost no toxicity to mice and is safe.
TAT-CIRP reduces cerebral ischemic injury in rhesus monkeys.
Animal Model:
Middle cerebral artery (MCA) occlusion (MCAO) model in mouse
Dosage:
5 mg/kg, 10 mg/kg, 20 mg/kg
Administration:
IV; single dose or once daily for 7 days
Result:
Resulted better neurological function at 28 days after brain hemorrhage than the mice that received saline.
Did not induce elevation of any liver transaminases or biomarkers of renal dysfunction.
分子式
C123H206N56O33
分子量
2997.31
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
2-8°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)